Aged Blood Loss Surgical Cystectomy/*adverse effects/*methods Female Humans Length of Stay Male Middle Aged Operative Time Postoperative Complications/etiology Quality of Life Randomized Controlled Trials as Topic Robotic Surgical Procedures/*adverse effects/*methods Treatment Outcome Urinary Bladder/*surgery Urinary Bladder Neoplasms/surgery Urinary Diversion/*adverse effects/*methods

Cystectomy/*methods Humans Prognosis *Quality of Life Urinary Bladder Neoplasms/*surgery Bladder cancer Continent urinary diversion Incontinent urinary diversion Quality of life Radical cystectomy

Controlled Clinical Trials as Topic Cystectomy/*methods Female Humans Male *Quality of Life Reproducibility of Results Surveys and Questionnaires Treatment Outcome Urinary Bladder Neoplasms/pathology/psychology/*surgery Urinary Diversion/methods/*psychology *Urinary Reservoirs Continent Health related quality of life Ileal conduit Meta-analysis Orthotopic neobladder Radical cystectomy Urinary diversion

Humans Treatment Outcome Urinary Bladder Neoplasms/*surgery *Urinary Diversion *Urinary Reservoirs Continent

*Aminolevulinic Acid Cystectomy/methods Disease-Free Survival Humans Neoplasm Recurrence Local *Photosensitizing Agents Randomized Controlled Trials as Topic Urinary Bladder Neoplasms/diagnostic imaging/*surgery 5-aminolevulinic acid non-muscle invasive bladder cancer photodynamic diagnosis recurrence-free survival transurethral resection

Combined Modality Therapy Cystectomy/*methods Humans Lymph Node Excision/*methods Urinary Bladder Neoplasms/pathology/*surgery

Critical Pathways Cystectomy/*methods/rehabilitation Humans Length of Stay Postoperative Care/*methods Postoperative Complications/*epidemiology *Standard of Care Urinary Bladder Neoplasms/*surgery Urinary Diversion/*methods/rehabilitation Clinical pathways Collaborative care Cystectomy Enhanced recovery Fast track including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: None.

Carcinoma Transitional Cell/pathology/*surgery Electrocoagulation/*methods Humans Length of Stay Muscle Smooth/pathology Neoplasm Invasiveness *Neoplasm Recurrence Local Operative Time Prospective Studies Retrospective Studies Urinary Bladder/pathology/*surgery Urinary Bladder Neoplasms/pathology/*surgery

*Cystectomy Humans *Quality of Life Treatment Outcome Urinary Bladder Neoplasms/*surgery *Urinary Diversion *Urinary Reservoirs Continent